November 2021 Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID -19 and Other Antibody Therapeutics for Difficult to Treat Diseases "Nov 15, 2021 -- Executive Leadership

December 2021 "Early-stage studies of COVID-19 treatments from the likes of Vir Biotechnology Inc. and Sotrovimab is the first monoclonal antibody showing preclinical efficacy against all COVID-19 variants

In light of the current COVID-19 pandemic, the topic of immunothrombosis has become more relevant than ever, as a majority of COVID-19 patients display thrombi in the lung capillaries and other vascular

Paul Insel turned dry-lab science into a reframing of COVID-19 pathobiology as a GPCR signaling imbalance -19 didn't hold up. What came next was a series of papers reframing severe COVID-19 as a disease of signaling imbalance: Scientific Themes of the Conversation The angiotensin imbalance hypothesis of COVID-19 pathobiology — Severe COVID-19 may be a story of signaling imbalance, not just viral damage.

-19 pandemic. -19 and chemosensory science - how a global consortium formed from a handful of tweets and what it found COVID-19 taste loss was a scientific detour that became something larger Niv had not planned to work on COVID-19 - she had never worked on viruses and was cautious about entering a field she did not know -19 and chemosensory loss - how a global research consortium assembled from a handful of tweets 31:01

From struggling to grip mice in early animal studies to thesis delays during COVID-19, Serafini's journey